Intervention Review

Chlorambucil for patients with primary biliary cirrhosis

  1. Wei Xin Li1,
  2. Xiang Yan2,*,
  3. Chun Rui Shi2,
  4. Ai Ping Zhang2

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 12 SEP 2012

Assessed as up-to-date: 20 APR 2012

DOI: 10.1002/14651858.CD008714.pub2


How to Cite

Li WX, Yan X, Shi CR, Zhang AP. Chlorambucil for patients with primary biliary cirrhosis. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD008714. DOI: 10.1002/14651858.CD008714.pub2.

Author Information

  1. 1

    First Hospital of Lanzhou University, Division of Geriatrics, Lanzhou City, Gansu, China

  2. 2

    First Hospital of Lanzhou University, Lanzhou City, Gansu, China

*Xiang Yan, First Hospital of Lanzhou University, No. 1, Donggang West Road, Lanzhou City, Gansu, 730000, China. yanxiang2010@yahoo.com.cn. yanxiang2010@yahoo.com.cn.

Publication History

  1. Publication Status: New
  2. Published Online: 12 SEP 2012

SEARCH

Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
    http://wiley.force.com/Interface/ContactJournalCustomerServices_V2.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.